250 related articles for article (PubMed ID: 16432198)
1. The benzamide MS-275 is a potent, long-lasting brain region-selective inhibitor of histone deacetylases.
Simonini MV; Camargo LM; Dong E; Maloku E; Veldic M; Costa E; Guidotti A
Proc Natl Acad Sci U S A; 2006 Jan; 103(5):1587-92. PubMed ID: 16432198
[TBL] [Abstract][Full Text] [Related]
2. Histone hyperacetylation induces demethylation of reelin and 67-kDa glutamic acid decarboxylase promoters.
Dong E; Guidotti A; Grayson DR; Costa E
Proc Natl Acad Sci U S A; 2007 Mar; 104(11):4676-81. PubMed ID: 17360583
[TBL] [Abstract][Full Text] [Related]
3. MS-275 inhibits aroclor 1254-induced SH-SY5Y neuronal cell toxicity by preventing the formation of the HDAC3/REST complex on the synapsin-1 promoter.
Formisano L; Guida N; Laudati G; Mascolo L; Di Renzo G; Canzoniero LM
J Pharmacol Exp Ther; 2015 Feb; 352(2):236-43. PubMed ID: 25467131
[TBL] [Abstract][Full Text] [Related]
4. Valproate corrects the schizophrenia-like epigenetic behavioral modifications induced by methionine in mice.
Tremolizzo L; Doueiri MS; Dong E; Grayson DR; Davis J; Pinna G; Tueting P; Rodriguez-Menendez V; Costa E; Guidotti A
Biol Psychiatry; 2005 Mar; 57(5):500-9. PubMed ID: 15737665
[TBL] [Abstract][Full Text] [Related]
5. Antipsychotic subtypes can be characterized by differences in their ability to modify GABAergic promoter methylation.
Dong E; Grayson DR; Guidotti A; Costa E
Epigenomics; 2009 Oct; 1(1):201-11. PubMed ID: 22122643
[TBL] [Abstract][Full Text] [Related]
6. Histone deacetylase inhibitors decrease reelin promoter methylation in vitro.
Mitchell CP; Chen Y; Kundakovic M; Costa E; Grayson DR
J Neurochem; 2005 Apr; 93(2):483-92. PubMed ID: 15816871
[TBL] [Abstract][Full Text] [Related]
7. Clozapine and sulpiride but not haloperidol or olanzapine activate brain DNA demethylation.
Dong E; Nelson M; Grayson DR; Costa E; Guidotti A
Proc Natl Acad Sci U S A; 2008 Sep; 105(36):13614-9. PubMed ID: 18757738
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the action of antipsychotic subtypes on valproate-induced chromatin remodeling.
Guidotti A; Dong E; Kundakovic M; Satta R; Grayson DR; Costa E
Trends Pharmacol Sci; 2009 Feb; 30(2):55-60. PubMed ID: 19110320
[TBL] [Abstract][Full Text] [Related]
9. Antidepressant actions of histone deacetylase inhibitors.
Covington HE; Maze I; LaPlant QC; Vialou VF; Ohnishi YN; Berton O; Fass DM; Renthal W; Rush AJ; Wu EY; Ghose S; Krishnan V; Russo SJ; Tamminga C; Haggarty SJ; Nestler EJ
J Neurosci; 2009 Sep; 29(37):11451-60. PubMed ID: 19759294
[TBL] [Abstract][Full Text] [Related]
10. Identification of novel isoform-selective inhibitors within class I histone deacetylases.
Hu E; Dul E; Sung CM; Chen Z; Kirkpatrick R; Zhang GF; Johanson K; Liu R; Lago A; Hofmann G; Macarron R; de los Frailes M; Perez P; Krawiec J; Winkler J; Jaye M
J Pharmacol Exp Ther; 2003 Nov; 307(2):720-8. PubMed ID: 12975486
[TBL] [Abstract][Full Text] [Related]
11. Differential regulation of Bdnf expression in cortical neurons by class-selective histone deacetylase inhibitors.
Koppel I; Timmusk T
Neuropharmacology; 2013 Dec; 75():106-15. PubMed ID: 23916482
[TBL] [Abstract][Full Text] [Related]
12. Histone deacetylase inhibition alters histone methylation associated with heat shock protein 70 promoter modifications in astrocytes and neurons.
Marinova Z; Leng Y; Leeds P; Chuang DM
Neuropharmacology; 2011 Jun; 60(7-8):1109-15. PubMed ID: 20888352
[TBL] [Abstract][Full Text] [Related]
13. Targeted acetylation of NF-kappaB/RelA and histones by epigenetic drugs reduces post-ischemic brain injury in mice with an extended therapeutic window.
Lanzillotta A; Pignataro G; Branca C; Cuomo O; Sarnico I; Benarese M; Annunziato L; Spano P; Pizzi M
Neurobiol Dis; 2013 Jan; 49():177-89. PubMed ID: 22971966
[TBL] [Abstract][Full Text] [Related]
14. A selective HDAC 1/2 inhibitor modulates chromatin and gene expression in brain and alters mouse behavior in two mood-related tests.
Schroeder FA; Lewis MC; Fass DM; Wagner FF; Zhang YL; Hennig KM; Gale J; Zhao WN; Reis S; Barker DD; Berry-Scott E; Kim SW; Clore EL; Hooker JM; Holson EB; Haggarty SJ; Petryshen TL
PLoS One; 2013; 8(8):e71323. PubMed ID: 23967191
[TBL] [Abstract][Full Text] [Related]
15. Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study.
Guidotti A; Auta J; Davis JM; Di-Giorgi-Gerevini V; Dwivedi Y; Grayson DR; Impagnatiello F; Pandey G; Pesold C; Sharma R; Uzunov D; Costa E
Arch Gen Psychiatry; 2000 Nov; 57(11):1061-9. PubMed ID: 11074872
[TBL] [Abstract][Full Text] [Related]
16. Valproate administration to mice increases histone acetylation and 5-lipoxygenase content in the hippocampus.
Yildirim E; Zhang Z; Uz T; Chen CQ; Manev R; Manev H
Neurosci Lett; 2003 Jul; 345(2):141-3. PubMed ID: 12821190
[TBL] [Abstract][Full Text] [Related]
17. Valproic acid promotes neuronal differentiation by induction of proneural factors in association with H4 acetylation.
Yu IT; Park JY; Kim SH; Lee JS; Kim YS; Son H
Neuropharmacology; 2009 Feb; 56(2):473-80. PubMed ID: 19007798
[TBL] [Abstract][Full Text] [Related]
18. Experimental therapy of malignant gliomas using the inhibitor of histone deacetylase MS-275.
Eyüpoglu IY; Hahnen E; Tränkle C; Savaskan NE; Siebzehnrübl FA; Buslei R; Lemke D; Wick W; Fahlbusch R; Blümcke I
Mol Cancer Ther; 2006 May; 5(5):1248-55. PubMed ID: 16731757
[TBL] [Abstract][Full Text] [Related]
19. Histone deacetylase inhibitors reverse age-related increases in side effects of haloperidol in mice.
Montalvo-Ortiz JL; Fisher DW; Rodríguez G; Fang D; Csernansky JG; Dong H
Psychopharmacology (Berl); 2017 Aug; 234(16):2385-2398. PubMed ID: 28421257
[TBL] [Abstract][Full Text] [Related]
20. Effects of perinatal hypothyroidism on regulation of reelin and brain-derived neurotrophic factor gene expression in rat hippocampus: Role of DNA methylation and histone acetylation.
Sui L; Li BM
Steroids; 2010 Dec; 75(12):988-97. PubMed ID: 20600205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
